Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies,... ByInvesting ...
Carisma Therapeutics stock a buy at D. Boral Capital, HER2 & platform value in focus On Monday, Carisma Therapeutics Inc (NASDAQ: CARM) retained a favorable outlook from D. Boral (OTC:BOALY ...